AGN-745
AGN-745 is a chemically modified siRNA targeted to VEGFR-1. It is used for the study of Macular degeneration.
Product Specifications
CAS Number
1255908-66-7
Product Name Alternative
AGN-211745; Sirna-027
UNSPSC
12352208
Target
VEGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Others
Smiles
[AGN-745]
References & Citations
[1]Jiang J, Zhang X, Tang Y, Li S, Chen J. Progress on ocular siRNA gene-silencing therapy and drug delivery systems. Fundam Clin Pharmacol. 2021;35 (1) :4-24.|[2]Shen J, Samul R, Silva RL, et al. Suppression of ocular neovascularization with siRNA targeted to VEGF receptor 1. Gene Ther. 2006;13 (3) :225-234.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
131279-ML750 100 µL
Phosphodiesterase 8A (PDE8A, High Affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic Phosphodiesterase 8A, FLJ16150, HsT19550) (MaxLight 750) discontinued
Sign In for Pricing
View Details